journal article·2019-11-05Open access

Regulation of Osteogenic Markers at Late Stage of Osteoblast Differentiation in Silicon and Zinc Doped Porous TCP

Gary A. Fielding, Naboneeta Sarkar, Sahar Vahabzadeh, Susmita Bose

Abstract

Calcium phosphates (CaPs) are one of the most widely used synthetic materials for bone grafting applications in the orthopedic industry. Recent trends in synthetic bone graft applications have shifted towards the incorporation of metal trace elements that extend the performance of CaPs to have osteoinductive properties. The objective of this study is to investigate the effects of silicon (Si) and zinc (Zn) dopants in highly porous tricalcium phosphate (TCP) scaffolds on late-stage osteoblast cell differentiation markers. In this study, an oil emulsion method is utilized to fabricate highly porous SiO2 doped β-TCP (Si-TCP) and ZnO doped β-TCP (Zn-TCP) scaffolds through the incorporation of 0.5 wt.% SiO2 and 0.25 wt.% ZnO, respectively, to the β-TCP scaffold. Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) is utilized to analyze the mRNA expression of osteoprotegerin (OPG), receptor activator of nuclear kappa beta ligand (RANKL), bone morphogenetic protein 2 (BMP2), and runt-related transcription factor 2 (Runx2) at the later stage of osteoblast differentiation, day 21 and day 28. Results show that the addition of Si and Zn to the β-TCP structure inhibited the β to α-TCP phase transformation and enhance the density without affecting the dissolution properties. Normal BMP-2 and Runx2 transcriptions are observed in both Si-TCP and Zn-TCP scaffolds at the initial time point, as demonstrated by RT-qPCR. Moreover, the addition of both Si and Zn positively regulate the osteoprotegerin: receptor activator of nuclear factor k-β ligand (OPG:RANKL) ratio at 21-days for Si-TCP and Zn-TCP scaffolds. These results demonstrate the effects of Si and Zn doped porous β-TCP scaffolds on the upregulation of osteoblast marker gene expression including OPG, RANKL, BMP-2, and Runx2, indicating the role of trace elements on the effective regulation of late-stage osteoblast cell differentiation markers.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

W. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164-2920, USA

Funding

(NIAMS, 1-R01-AR-066361) and National Institute of Health (N1H-R01-EB-007351)

References (41)

Show source-provided references
1. Silver doped resorbable tricalcium phosphate scaffolds for bone graft applications10.1016/j.msec.2017.04.132 ↗
2. 3D-printed β-TCP bone tissue engineering scaffolds: Effects of chemistry on in vivo biological properties in a rabbit tibia model10.1557/jmr.2018.233 ↗
3. Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty10.1016/j.biomaterials.2008.12.035 ↗
4. Macroporous biphasic calcium phosphate scaffold with high permeability/porosity ratio10.1089/107632703322066714 ↗
5. Peri-implant bone response around a human hydroxyapatite-coated implant retrieved after a 10-year loading period: A case report10.11607/jomi.2503 ↗
6. Bone formation and resorption in patients after implantation of beta-tricalcium phosphate blocks with 60% and 75% porosity in opening-wedge high tibial osteotomy10.1002/jbm.b.31041 ↗
7. Effects of VEGF loading on scaffold-confined vascularization10.1002/jbm.a.32902 ↗
8. Volumetric bone regenerative efficacy of biphasic calcium phosphate-collagen composite block loaded with rhBMP-2 in vertical bone augmentation model of a rabbit calvarium10.1002/jbm.a.34278 ↗
9. Short (15 minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro10.1089/ten.tea.2012.0133 ↗
10. Repair of segmental bone defects in rabbit tibiae using a complex of beta-tricalcium phosphate, type I collagen, and fibroblast growth factor-210.1016/j.biomaterials.2006.05.031 ↗
11. A Macroporous Bioreactor Super Activated by the Recombinant Human Transforming Growth Factor-β(3)10.3389/fphys.2012.00172 ↗
12. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned10.1016/j.spinee.2011.04.023 ↗
13. A review of the clinical side effects of bone morphogenetic protein-210.1089/ten.teb.2015.0357 ↗
14. Mechanical and biological properties of ZnO, SiO2, and Ag2O doped plasma sprayed hydroxyapatite coating for orthopaedic and dental applications10.1016/j.actbio.2019.05.020 ↗
15. Silicon deprivation decreases collagen formation in wounds and bone, and ornithine transaminase enzyme activity in liver10.1385/BTER:89:3:251 ↗
16. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort10.1359/JBMR.0301225 ↗
17. Bioactive silicate materials stimulate angiogenesis in fibroblast and endothelial cell co-culture system through paracrine effect10.1016/j.actbio.2013.02.014 ↗
18. Role of nutritional zinc in the prevention of osteoporosis10.1007/s11010-009-0358-0 ↗
19. IGF-loaded silicon and zinc doped brushite cement: Physico-mechanical characterization and in vivo osteogenesis evaluation10.1039/c5ib00114e ↗
20. Effects of MgO, ZnO, SrO, and SiO2 in tricalcium phosphate scaffolds on in vitro gene expression and in vivo osteogenesis10.1016/j.msec.2018.10.073 ↗
21. ZnO, SiO2, and SrO doping in resorbable tricalcium phosphates: Influence on strength degradation, mechanical properties, and in vitro bone-cell material interactions10.1002/jbm.b.32789 ↗
22. Effects of SiO2 and ZnO doping on mechanical and biological properties of 3D printed TCP scaffolds10.1016/j.dental.2011.09.010 ↗
23. Effects of SiO2, SrO, MgO, and ZnO dopants in tricalcium phosphates on osteoblastic Runx2 expression10.1002/jbm.a.34909 ↗
24. SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo10.1016/j.actbio.2013.07.009 ↗
25. Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics10.1016/j.tibtech.2013.06.005 ↗
26. Effects of Zinc and Strontium Substitution in Tricalcium Phosphate on Osteoclast Differentiation and Resorption10.1039/C2BM00012A ↗
27. Crystallization behavior of silica-calcium phosphate biocomposites: XRD and FTIR studies10.1007/s10856-004-5677-9 ↗
28. Preparation of micro-porous bioceramic containing silicon-substituted hydroxyapatite and beta-tricalcium phosphate10.1016/j.msec.2017.02.065 ↗
29. Enhanced in vivo bone and blood vessel formation by iron oxide and silica doped 3D printed tricalcium phosphate scaffolds10.1007/s10439-018-2040-8 ↗
30. Crystal Structure Analysis of Si- and Zn-Codoped Tricalcium Phosphate by Neutron Powder Diffraction10.1111/j.1551-2916.2007.01764.x ↗
31. Effects of additives on sintering and some properties of calcium phosphates with various Ca/P ratios10.1007/BF00576536 ↗
32. An improvement in sintering property of beta-tricalcium phosphate by addition of calcium pyrophosphate10.1016/S0142-9612(01)00201-0 ↗
33. Effects of B and H2O on liquidus phase relations in the haplogranite system at l kbar
34. Calcium Phosphate-Based Resorbable Ceramics: Influence of MgO, ZnO, and SiO2 Dopants10.1111/j.1551-2916.2006.01207.x ↗
35. Driessens, F., and Verbeeck, R. (1990). Biominerals, CRC Press.
36. Bone substitute fabrication based on dissolution-precipitation reactions10.3390/ma3021138 ↗
37. Bradley, E.W., Westendorf, J.J., van Wijnen, A.J., and Dudakovic, A. (2018). Osteoblasts: Function, Development, and Regulation. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, John Wiley & Sons, Inc.10.1002/9781119266594.ch4 ↗
38. Biology of RANK, RANKL, and osteoprotegerin10.1186/ar2165 ↗
39. Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling10.1016/j.cmet.2005.11.011 ↗
40. Mechanical stress regulates osteogenic differentiation and RANKL/OPG ratio in periodontal ligament stem cells by the Wnt/β-catenin pathway10.1016/j.bbagen.2016.05.003 ↗
41. Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells10.1152/ajpgi.00119.2007 ↗